Please login to the form below

Mosquirix

This page shows the latest Mosquirix news and features for those working in and with pharma, biotech and healthcare.

Dosing of GSK's malaria vaccine due to start in 2018

GSK's vaccine – also known as Mosquirix – is considered to have limited efficacy, but the sheer scale of the public health problem posed by malaria in some areas of the world

Latest news

Malaria vaccine is first to provide 'sustained protection'

The results have been published in the journal Nature Medicine. That data looks pretty good when compared to trials of the Mosquirix malaria vaccine developed by GlaxoSmithKline (GSK) - which has already ... Mosquirix (formerly known as RTS, S) also
Shire and Baxalta drugs among CHMP's latest recommendations

Mosquirix outside the EU.
World first as CHMP backs GSK malaria vaccine Mosquirix

The European regulator's Committee for Medicinal Products for Human Use (CHMP) gave Mosquirix a positive opinion for use outside the EU in young children alongside established antimalarial interventions. . ... The CHMP and GSK's biologics unit agreed
GSK chief positive about future

In addition, phase III trials started this quarter for Mosquirix, GSK's malaria vaccine. .
UK pledge to HIV/AIDS vaccine

In November last year, it purchased 300 million doses of GlaxoSmithKline's investigational malaria vaccine, Mosquirix, to create demand for the product.

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch January 2018

contain the adjuvant QS-21 Stimulon. In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA. GSK's malarial vaccine, Mosquirix which also contains

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Medical Writer: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Subscribe to our email news alerts

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

The 2019 CPhI Pharma Index Report: Examining this year’s industry performance...
Five key trends in precision and personalised healthcare: Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications: Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...